Momenta pharmaceuticals Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Momenta pharmaceuticals Contact Number

Momenta Pharmaceuticals, Inc. Company Profile Cambridge

1 hours ago Dnb.com Get All

(617) 491-9700301 Binney St. Cambridge , MA , 02142-1071. United States. See other locations. Phone. (617) 491-9700. Company Description. Biotech Momenta Pharmaceuticals specializes in unpacking and engineering complex molecules in order to copy existing biologic drugs, develop complex generic drugs, and discover new drugs.

Cash and Cash Equivalents: $382.51
Tangible Fixed Assets: $11.5
Other Current Assets: $156.61
TOTAL CURRENT ASSETS: $539.13

Website: https://www.dnb.com/business-directory/company-profiles.momenta_pharmaceuticals_inc.005ae82911aa8a8c703df6e92f857b58.html

Category: Contact NumberShow more

Contact us Momenta

6 hours ago Momentagroup.com Get All

020-08-03Contact us Momenta-Build 2020-08-03T13:08:28+00:00 At Momenta we are passionate about people and always welcome a conversation. We would be delighted to hear from you.

Website: https://momentagroup.com/contact-us/

Category: Contact SupportShow more

Momenta Pharmaceuticals, Inc. Home

7 hours ago Momentapharma.com Get All

800-526-7736If you require immediate assistance or wish to report an adverse event or product quality complaint, Janssen Medical Information can be reached by phone at: 1-800-JANSSEN (1-800-526-7736), Monday through Friday from 9:00 AM to 8:00 PM ET. Please see below for specific contact information: Career Opportunities. Media Contacts. Patient Assistance.

Website: https://www.momentapharma.com/home/default.aspx

Category: Home PhoneShow more

Momenta Pharmaceuticals Crunchbase Company Profile & Funding

3 hours ago Crunchbase.com Get All

Contact Email [email protected] Phone Number (617)621-0431. Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the characterization and process engineering of complex molecules. These complex molecules include proteins, polypeptides, and cell surface polysaccharides, such as heparan-sulfate proteoglycans.

Website: https://www.crunchbase.com/organization/momenta-pharmaceuticals

Category: Contact NumberShow more

History of Changes for Study: NCT03866577

Just Now Clinicaltrials.gov Get All

617-491-9700Central Contact Person: Momenta General Queries Telephone: +1 617-491-9700 Email: [email protected]: Study Officials: Momenta General Queries Study Director Momenta Pharmaceuticals, Inc. Locations: United States, California: Momenta Investigational Site [Not yet recruiting] Los Angeles, California, United States, 90089

Conditions: Immune Thrombocytopenic Purpura (ITP)
Sponsor: Momenta Pharmaceuticals, Inc.

Website: https://clinicaltrials.gov/ct2/history/NCT03866577?V_16=View

Category: Contact NumberShow more

EIN 043561634 Momenta Pharmaceuticals Inc, Cambridge

7 hours ago Eintaxid.com Get All

Momenta Pharmaceuticals Inc is a corporation in Cambridge, Massachusetts. The employer identification number (EIN) for Momenta Pharmaceuticals Inc is 043561634. EIN for organizations is sometimes also referred to as taxpayer identification number or TIN or simply IRS Number. It is one of the corporates which submit 10-K filings with the SEC.

Website: https://eintaxid.com/company/043561634-momenta-pharmaceuticals-inc/

Category: Contact NumberShow more

Momenta Crunchbase Company Profile & Funding

Just Now Crunchbase.com Get All

Company Type For Profit. Contact Email contact@momenta.ai. Phone Number 86 (010)82526609. Momenta is an autonomous driving startup operating out of Beijing. Its deep-learning-based software in perception, HD semantic mapping, and data-driven path planning enables the realization of full autonomy. Momenta offer multi-level autonomous driving

Website: https://www.crunchbase.com/organization/momenta-ai

Category: Contact NumberShow more

Home Momenta

5 hours ago Momentagroup.com Get All

Founded in 2019, Momenta began its expansion into India through supporting one of its large global I.T clients recognised for their infrastructure solutions and service model. Since then Momenta India has grown exponentially servicing the in-territory requirements of a number of large global I.T and Big 4 consulting firms.

Website: https://momentagroup.com/

Category: Home PhoneShow more

Jo Beltramello HR Chief.. Momenta Pharmaceuticals

3 hours ago Zoominfo.com Get All

View Jo Beltramello's business profile as HR Chief & Infrastructure Officer at Momenta Pharmaceuticals. Find contact's direct phone number, email …

Website: https://www.zoominfo.com/p/Jo-Beltramello/-2021093194

Category: Contact NumberShow more

Safety and Tolerability of M254 in Healthy Volunteers and

7 hours ago Clinicaltrials.gov Get All

979 2018-0035Momenta Pharmaceuticals, Inc. ClinicalTrials.gov Identifier: NCT03866577 Other Study ID Numbers: CR108979 2018-003534-32 ( EudraCT Number ) MOM-M254-001 ( Other Identifier: Momenta Pharmaceuticals, Inc. ) First Posted: March 7, 2019 Key Record Dates: Last Update Posted: August 9, 2021 Last Verified: August 2021

Website: https://clinicaltrials.gov/ct2/show/NCT03866577

Category: Contact NumberShow more

Meet the team Momenta

5 hours ago Momentagroup.com Get All

The people behind Momenta Momenta have over 100 in-house team specialists, globally. Our people are the backbone of our organisation and together are committed to delivering service excellence and on-going support to our clients and associates around the world. Our high performing teams are led by skilled industry

Website: https://momentagroup.com/about/meet-the-team/

Category: Contact NumberShow more

Momenta Creativity Unbound

4 hours ago Momenta.com Get All

Momenta's line of crating goods reflect the latest in design & style. We pride ourselves on producing high-quality crafting products that help spark your inner creative fire.

Website: https://www.momenta.com/

Category: Contact NumberShow more

Virdante Pharmaceuticals Crunchbase Company Profile

4 hours ago Crunchbase.com Get All

617-300-8500Contact Email [email protected] Phone Number 617-300-8500. Virdante Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes drugs for autoimmune and inflammatory diseases. It offers antibody and Fc-fusion drugs to treat auto-immune diseases. The company was formerly known as Centaurus Pharmaceuticals and changed its

Website: https://www.crunchbase.com/organization/virdante-pharmaceuticals

Category: Contact NumberShow more

Momenta Company Profile Office Locations, Competitors

7 hours ago Craft.co Get All

The stock price of Momenta Pharmaceuticals, a pharmaceutical company best known for its immunology therapies, has rallied around 26% over recent weeks (vs. about a 50% gain in the S&P 500) to $31 as of August 18, after falling to a low of $24 in late March, when a rapid increase in the number

Website: https://craft.co/momenta-ai

Category: Contact NumberShow more

Momenta Pharmaceuticals LinkedIn

6 hours ago Linkedin.com Get All

Momenta Pharmaceuticals 16,683 followers on LinkedIn. Momenta is a biotechnology company with a validated innovative scientific platform focused on discovering and developing novel therapeutics

Website: https://www.linkedin.com/company/momenta-pharmaceuticals

Category: Contact NumberShow more

Momenta Pharmaceuticals Company Profile Office Locations

Just Now Craft.co Get All

Momenta Pharmaceuticals $23.87 M in annual revenue in FY 2019. See insights on Momenta Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Website: https://craft.co/momenta-pharmaceuticals

Category: Contact NumberShow more

Momenta Pharmaceuticals, Inc. in Cambridge MA Company

7 hours ago Corporationwiki.com Get All

2 Known Addresses. 320 Bent St Cambridge, MA 02141 675 W Kendall St Cambridge, MA 02142. These addresses are known to be associated with Momenta Pharmaceuticals, Inc. however they may be inactive or mailing addresses only. Please verify address for mailing or other purposes. Wiki.

Website: https://www.corporationwiki.com/Massachusetts/Cambridge/momenta-pharmaceuticals-inc/55347310.aspx

Category: Contact NumberShow more

A Study to Evaluate the Safety, Tolerability, Efficacy

7 hours ago Clinicaltrials.gov Get All

281-004 2018Momenta Pharmaceuticals, Inc. ClinicalTrials.gov Identifier: NCT03772587 Other Study ID Numbers: MOM-M281-004 2018-002247-28 ( EudraCT Number ) First Posted: December 11, 2018 Key Record Dates: Last Update Posted: March 5, 2021 Last Verified: March 2021 Individual Participant Data (IPD) Sharing Statement:

Website: https://clinicaltrials.gov/ct2/show/NCT03772587

Category: Contact NumberShow more

Jobs with Momenta Pharmaceuticals, Inc.

Just Now Biospace.com Get All

Momenta Pharmaceuticals Reports Second Quarter 2020 Financial and Operating Results. 8/10/2020. Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases, today reported its financial results for the second …

Website: https://www.biospace.com/employer/248366/momenta-pharmaceuticals-inc-/

Category: Contact NumberShow more

Momenta Pharmaceuticals Inc (MNTA) 10K Annual Reports

6 hours ago Last10k.com Get All

In January 2020, Momenta announced interim results, featuring early favorable responses to M254 (5/6 patients on treatment exhibited platelet counts ≥ 50 x 10 9 /L). Based on these data, the Company is expanding Part B to include at least one additional lower dose cohort and to augment the number of patients in existing cohorts.

Website: https://last10k.com/sec-filings/mnta

Category: Contact NumberShow more

Momenta Pharmaceuticals Email Format momentapharma.com

6 hours ago Rocketreach.co Get All

Momenta Pharmaceuticals uses 6 email formats: 1. first_initial [email protected] (46.1%). Enter a name to find & verify an email >>> Rocketreach finds email, phone & social media for 450M+ professionals.

Website: https://rocketreach.co/momenta-pharmaceuticals-email-format_b5c65933f42e0caf

Category: Contact NumberShow more

Contact MedSource

Just Now Medsource.com Get All

(919) 792-3740Raleigh, NC 5430 Wade Park Blvd. Suite #208 Raleigh, NC 27607 Phone: (919) 792-3740 Toll-Free Number: (877) 269-2987. Cary, NC 100 Regency Forest Drive Suite 160 Cary, NC 27518 Phone: (+1) 919-401-8003. San Diego, CA 11622 El Camino Real, 1st Floor San Diego, CA 92130. Toronto, Canada 40 University Avenue, Suite 904 Toronto, ON, M5J 1T1 CA

Website: https://medsource.com/contact/

Category: Contact SupportShow more

Momenta, Inc. LinkedIn

5 hours ago Linkedin.com Get All

Momenta, Inc. 1,485 followers on LinkedIn. Momenta is the leading designer and distributor of craft products to retailers worldwide. Combining propriety market …

Website: https://www.linkedin.com/company/momenta-inc.

Category: Contact NumberShow more

Momenta Pharmaceuticals Announces Appointments in

5 hours ago S24.q4cdn.com Get All

trademarks, or service marks are property of their respective owners and are not the property of Momenta Pharmaceuticals, Inc. SOURCE Momenta Pharmaceuticals, Inc. -0- 11/16/2004 /CONTACT: Michael Lawless, Senior Director, Investor Relations, +1-

Website: https://s24.q4cdn.com/902352448/files/doc_news/archive/daaca08c-5e1d-492d-be07-bb8302f4a39c.pdf

Category: Contact NumberShow more

MOMENTA PHARMACEUTICALS, INC. : Shareholders Board …

1 hours ago Marketscreener.com Get All

Momenta Pharmaceuticals, Inc. is a biotechnology company. The Company is focused on developing generic versions of drugs, biosimilars and therapeutics for oncology and autoimmune disease. The Company has developed generic version of LOVENOX (enoxaparin sodium injection) and COPAXONE (glatiramer acetate injection).

Website: https://www.marketscreener.com/quote/stock/MOMENTA-PHARMACEUTICALS-10057/company/

Category: Contact NumberShow more

Companies with 'M' EIN, Address and Contact Page 15

1 hours ago Eintaxid.com Get All

617 491-9700EIN Number: 04-3561634 Address: 301 Binney Street, Cambridge, Massachusetts Doing Business As: Momenta Pharmaceuticals Inc Phone: 617 491-9700

Website: https://eintaxid.com/companies/m/?page=15

Category: Contact SupportShow more

A Study to Evaluate the Safety, Efficacy, Pharmacokinetics

1 hours ago Clinicaltrials.gov Get All

A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Pregnant Women at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn (HDFN) - Full Text View.

Website: https://www.clinicaltrials.gov/ct2/show/NCT03842189

Category: Contact NumberShow more

Arpita Patel Sr. Manager, Quality Assurance Kiniksa

9 hours ago Linkedin.com Get All

Momenta Pharmaceuticals Jan 2017 - Jan 2019 2 • Reviewed all site and product specific MS,MF and PRs to compile Part number of raw materials …

Title: Sr. Manager, Quality …
Location: Waltham, Massachusetts
1. 500+ connections

Website: https://www.linkedin.com/in/arpita-patel-1276b523

Category: Contact NumberShow more

Momenta LinkedIn

3 hours ago Linkedin.com Get All

Momenta builds communication and influence skills in the insurance, disability and unemployment sectors through face-to-face and online learning solutions. This means a great customer experience

Website: https://www.linkedin.com/company/momenta-au

Category: Contact NumberShow more

Momenta and CSL Announce Collaboration and License Agreement

1 hours ago Cslbehring.com Get All

617-395-5189MOMENTA INVESTOR CONTACT: Sarah Carmody Momenta Pharmaceuticals 1-617-395-5189 [email protected] MOMENTA MEDIA CONTACT: Karen Sharma MacDougall Biomedical Communications 1-781-235-3060 Momenta@macbiocom.com. CSL INVESTOR CONTACT: Mark Dehring CSL +61 3 9389 3407 [email protected]

Website: https://www.cslbehring.com/newsroom/2017/20170105-momenta-collaboration

Category: Contact NumberShow more

Peter Barrett Partner @ Atlas Venture Crunchbase

7 hours ago Crunchbase.com Get All

Barrett joined Atlas Venture, an early stage life sciences venture capital fund, in 2002 and is a partner in the life sciences group. Previously, he was a co-founder, Executive Vice President and Chief Business Officer of Celera Genomics. Prior to that, Mr. Barrett held several senior management positions at The Perkin-Elmer Corporation, most.

Website: https://www.crunchbase.com/person/peter-barrett

Category: Contact NumberShow more

Johnson & Johnson to Acquire Momenta Pharmaceuticals

7 hours ago Investingnews.com Get All

Momenta’s expertise in FcRn mechanisms is especially important for nipocalimab as it supports and accelerates the development of a medicine designed to target a number of autoantibody-driven

Website: https://investingnews.com/news/medical-device-investing/johnson-johnson-to-acquire-momenta-pharmaceuticals/

Category: Contact NumberShow more

Is Momenta Pharmaceuticals, Inc.'s (NASDAQ:MNTA) CEO

5 hours ago Finance.yahoo.com Get All

Our data indicates that Momenta Pharmaceuticals, Inc. is worth US$3.4b, and total annual CEO compensation was reported as US$4.6m for the year to December 2018. We think total compensation is more

Website: https://finance.yahoo.com/news/momenta-pharmaceuticals-inc-nasdaq-mnta-150002476.html

Category: Contact NumberShow more

Momenta Pharmaceuticals, Inc. DEF 14A Apr. 24, 2020 5:28

9 hours ago Seekingalpha.com Get All

to approve the amendment and restatement of the Momenta Pharmaceuticals, Inc. 2013 Incentive Award Plan, which, among other things, increases the …

Website: https://seekingalpha.com/filing/4943952

Category: Contact NumberShow more

Contact Elpis Biopharmaceuticals

4 hours ago Elpisbiopharmaceuticals.com Get All

Ahmad is the Vice President of Business Development and Corporate Strategy. Previously, he held roles in business development and corporate strategy at Epizyme and Momenta Pharmaceuticals. His diverse drug development experience includes roles in management consulting, commercial strategy, corporate finance, and program and portfolio management.

Website: https://elpisbiopharmaceuticals.com/contact/

Category: Contact SupportShow more

Implications of the BPCIA on the IP Strategies of Brand

Just Now Sternekessler.com Get All

12.29.235

1. From the outset, it was clear that the BPCIA’s abbreviated pathway for biosimilars is fundamentally different from the abbreviated pathway for small molecule drugs established by the Hatch-Waxman Act in 1984. Although both statutes provide a mechanism by which patent disputes can be litigated and resolved prior to the actual launch of the biosimilar or generic product, there are few other similarities between the two statutes. Importantly, whereas Hatch-Waxman established the “Orange Book,” which provides a publicly-available listing of patents covering the brand product, no equivalent public patent listing is provided under the BPCIA. Instead, the BPCIA provides for a complicated mechanism involving the private exchange of information and patent lists between the biosimilar applicant and the reference product sponsor (known colloquially as the “Patent Dance”) which is designed to enable the parties to jointly identify and agree on the patents that will be the subject of the statuto...

Website: https://www.sternekessler.com/news-insights/publications/implications-bpcia-ip-strategies-brand-companies-and-biosimilar

Category: Contact NumberShow more

Alan Crane Chief Executive Officer @ XTuit

4 hours ago Crunchbase.com Get All

Alan Crane is a general partner at Polaris Venture Partners and was a Venture Partner from 2002 until 2009. From 2006 to 2009, he co-founded and served as CEO of Cerulean Pharma, a nanotechnology focused pharmaceutical company. From 2002 until 2006, Mr. Crane was President and CEO of Momenta Pharmaceuticals (NASDAQ: MNTA).

Website: https://www.crunchbase.com/person/alan-crane

Category: Contact NumberShow more

Momenta Pharmaceuticals' Technology Featured in Nature …

5 hours ago S24.q4cdn.com Get All

617-395-5116Momenta's actual results could differ materially from those stated or implied in forward-looking statements due to a number of trademarks, or service marks are property of their respective owners and are not the property of Momenta Pharmaceuticals, Inc. Contact: Momenta Pharmaceuticals, Inc., Valerie Threlfall, 617-395-5116

Website: https://s24.q4cdn.com/902352448/files/doc_news/archive/55bb3f00-7639-4c38-b5c2-4308aca569fb.pdf

Category: Tech SupportShow more

Analysts Just Shipped A Stunning Upgrade To Their Momenta

4 hours ago Finance.yahoo.com Get All

Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's forecasts.The consensus statutory numbers

Website: https://finance.yahoo.com/news/analysts-just-shipped-stunning-upgrade-115507848.html

Category: Contact NumberShow more

Momenta Pharmaceuticals Reports First Quarter 2020

1 hours ago Finance.yahoo.com Get All

617-395-5189INVESTOR CONTACT: MEDIA CONTACT: Patty Eisenhaur. Karen Sharma. Momenta Pharmaceuticals. MacDougall Biomedical Communications. 1-617-395-5189. 1-781-235-3060. [email protected] Momenta

Website: https://finance.yahoo.com/news/momenta-pharmaceuticals-reports-first-quarter-110010921.html

Category: Contact NumberShow more

Average Momenta Pharmaceuticals, Inc Salary PayScale

3 hours ago Payscale.com Get All

At Momenta Pharmaceuticals, Inc, they provide pension benefits for their employees. To help guarantee a steady cash source later in life, a large number of employees enroll in …

Website: https://www.payscale.com/research/US/Employer=Momenta_Pharmaceuticals,_Inc/Salary

Category: Contact NumberShow more

Is Momenta Stock a good investment? MNTA Macroaxis

Just Now Macroaxis.com Get All

To calculate Momenta Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Momenta Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations.

Website: https://www.macroaxis.com/stock/MNTA/Momenta-Pharmaceuticals

Category: Contact NumberShow more

Momenta Enterprise Value over EBITDA from 2010 to 2021

Just Now Cdn-macroaxis.netdna-ssl.com Get All

From 2010 to 2021 Momenta Pharmaceuticals Enterprise Value over EBITDA quarterly data regression line had arithmetic mean of (12.98) and significance of 0.84. Momenta Pharmaceuticals Gross Profit is projected to decrease significantly based on the last few years of reporting. The past year's Gross Profit was at 21.48 Million.

Website: http://cdn-macroaxis.netdna-ssl.com/financial-statements/MNTA/Enterprise-Value-over-EBITDA

Category: Contact NumberShow more

TNF Alpha Inhibitors Global Market Report 2021: COVID19

Just Now Finance.yahoo.com Get All

The global TNF alpha inhibitors market is expected to grow from $38.85 billion in 2020 to $40.33 billion in 2021 at a compound annual growth rate (CAGR) of 3.8%.

Website: https://finance.yahoo.com/news/tnf-alpha-inhibitors-global-market-110100833.html

Category: Contact NumberShow more

MNTA Stock Momenta Pharmaceuticals Inc SEC Filings

Just Now Sec.report Get All

Ticker: MNTA. documents---0.00095105171203613. Momenta Pharmaceuticals Inc is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Momenta Pharmaceuticals Inc is primarely in the business of biological products (no diagnostic substances). For financial reporting, their fiscal year ends on December 31st.

Website: https://sec.report/Ticker/MNTA

Category: Contact NumberShow more

Johnson & Johnson Buys Momenta in $6.5B Pharma Acquisition

3 hours ago Pharmanewsintel.com Get All

August 25, 2020 - Johnson & Johnson recently announced that it signed a $6.5 billion pharma acquisition deal with Momenta Pharmaceuticals Inc., a company that discovers novel therapies for immune-mediated diseases.. The company stated that this acquisition provides an opportunity for the Janssen Pharmaceutical Companies of Johnson & Johnson to …

Website: https://pharmanewsintel.com/news/johnson-johnson-buys-momenta-in-6.5b-pharma-acquisition-deal

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What do you need to know about Momenta Pharmaceuticals?

Momenta is a biotechnology company with a validated innovative scientific platform focused on discovering and developing novel therapeutics to treat rare, immune-mediated diseases. Our scientific foundation is based on a deep understanding of immune biology and disease analytics.

How much money has the company momenta raised?

The Company offers multi-level autonomous driving solutions as well as big data products and services. Momenta's latest funding round in March 2021 was reported to be $500 m. In total, Momenta has raised $703 m.

Where is the head office of momenta located?

Momenta head office located in the heart of the financial district in London, was founded almost 30 years ago. Having started off exclusively staffing the Financial Industry with leading contingent workforce, Momenta now operates across multiple sectors globally and continues to grow and innovate to best service our clients and associates.

Who are the members of the momenta team?

Our high performing teams are led by skilled industry professionals, who work alongside our clients to truly understand their needs and ensure all our resources are of the highest, professional standards. Join the Momenta team.

Popular Brands

Merck
Man
Maaden
Mcx
Midea
Metro
Mapfre